Edwards Lifesciences CorporationEWNYSE
Loading
Gross Profit Over TimeStrong
Percentile Rank100
3Y CAGR+4.0%
5Y CAGR+7.6%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+4.0%/yr
vs +10.8%/yr prior
5Y CAGR
+7.6%/yr
Recent deceleration
Acceleration
-6.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.74B | +9.7% |
| 2024 | $4.32B | +8.8% |
| 2023 | $3.97B | -5.8% |
| 2022 | $4.22B | +5.2% |
| 2021 | $4.01B | +21.9% |
| 2020 | $3.29B | +3.0% |
| 2019 | $3.19B | +14.0% |
| 2018 | $2.80B | +9.7% |
| 2017 | $2.55B | +18.3% |
| 2016 | $2.16B | - |